LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml
LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml is a medicine authorised by Swissmedic under authorisation number 70651. The authorisation holder is OmniVision AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 May 2026 and the authorisation is limited until 25 May 2031. ATC code S01ED51 places the medicine in the group Ophthalmologicals.
| Authorisation number | 70651 |
|---|---|
| Name | LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml |
| Full name | LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml, Augentropfen, Lösung im Einzeldosisbehältnis |
| Authorisation holder | OmniVision AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01ED51 |
| First authorisation | 26 May 2026 |
| Authorisation validity | 25 May 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml, Augentropfen, Lösung im Einzeldosisbehältnis | B | 26 May 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Einzeldose(n) | S01ED51 | 11.09.0. | B |
| 2 | 90 | Einzeldose(n) | S01ED51 | 11.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml authorised in Switzerland?
Yes. LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml is authorised by Swissmedic under authorisation number 70651, data as of 01 September 2026. The authorisation is limited until 25 May 2031.
Which dispensing category does LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml have?
LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml?
The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.